The safety and optimal dosage of an interleukin-17A inhibitor (secukinumab) in the treatment of psoriatic arthritis in a patient with concomitant hepatitis C virus infection by E. E. Gubar, T. V. Korotaeva, A. S. Starkova, M. M. Urumova

Subjects: Get full text

Changes in clinical, biochemical, immunological and integrative parameters in patients with chronic hepatitis C virus infection according to the virus genotype and the grade of act... by A. H. Lishnevska, M. D. Chemych

Subjects: “…chronic hepatitis c virus…”
Get full text

Efficacy and safety of sofosbuvir plus daclatasvir in hemodialysis patients with genotype 1b or 2a hepatitis C virus infection: a single-arm, prospective real-world study by Kaili Wang, Hongyu Yao, Xia Zhou, Hongling Liu, Jun Zhao

Subjects: Get full text

Improving the model of payment for medical care for chronic viral hepatitis C in the framework of the implementation of the Program of State Guarantees of Free Provision of Medical... by V. V. Omelyanovskiy, I. A. Zheleznyakova, A. V. Zuev, O. S. Plakhotnik, O. A. Volkova, L. M. Davydova, G. V. Trifonova, E. V. Semakova, E. A. Prokhorovich, A. S. Volkova

Subjects: “…chronic hepatitis c virus…”
Get full text

Performance of Elecsys^® HCV Duo Immunoassay for Diagnosis and Assessment of Treatment Response in HCV Patients with or without HIV Infection by Prooksa Ananchuensook, Jongkonnee Wongpiyabovorn, Anchalee Avihingsanon, Pisit Tangkijvanich

Subjects: Get full text